| __timestamp | Arrowhead Pharmaceuticals, Inc. | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 175000 | 28796000 |
| Thursday, January 1, 2015 | 382000 | 51168000 |
| Friday, January 1, 2016 | 158333 | 54383000 |
| Sunday, January 1, 2017 | 31407709 | 63924000 |
| Monday, January 1, 2018 | 16142321 | 90857000 |
| Tuesday, January 1, 2019 | 168795577 | 117850000 |
| Wednesday, January 1, 2020 | 87992066 | 124179000 |
| Friday, January 1, 2021 | 138287000 | 156184000 |
| Saturday, January 1, 2022 | 243231000 | 164365000 |
| Sunday, January 1, 2023 | 240735000 | 197516000 |
| Monday, January 1, 2024 | 3551000 |
Infusing magic into the data realm
In the competitive landscape of biotechnology, revenue generation is a key indicator of success. Over the past decade, Vericel Corporation and Arrowhead Pharmaceuticals, Inc. have been vying for dominance. From 2014 to 2023, Vericel consistently outperformed Arrowhead in revenue, with a notable peak in 2023, reaching approximately $198 million. In contrast, Arrowhead's revenue surged in 2022, peaking at around $243 million, a 50% increase from the previous year. However, by 2023, Arrowhead's revenue slightly declined to $241 million. This fluctuation highlights the volatile nature of the biotech industry, where innovation and market dynamics can rapidly shift financial outcomes. Notably, data for 2024 is incomplete, leaving room for speculation on future trends. As these companies continue to innovate, investors and industry watchers will be keenly observing their financial trajectories.
Incyte Corporation and Vericel Corporation: A Comprehensive Revenue Analysis
Bio-Techne Corporation or Vericel Corporation: Who Leads in Yearly Revenue?
Revenue Showdown: BioMarin Pharmaceutical Inc. vs Vericel Corporation
Breaking Down Revenue Trends: BioMarin Pharmaceutical Inc. vs Arrowhead Pharmaceuticals, Inc.
Revenue Insights: Ascendis Pharma A/S and Vericel Corporation Performance Compared
Cytokinetics, Incorporated and Arrowhead Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Telix Pharmaceuticals Limited and Arrowhead Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: ACADIA Pharmaceuticals Inc. vs Vericel Corporation
Who Generates More Revenue? ACADIA Pharmaceuticals Inc. or Arrowhead Pharmaceuticals, Inc.
Breaking Down Revenue Trends: Vericel Corporation vs Geron Corporation
Annual Revenue Comparison: Arrowhead Pharmaceuticals, Inc. vs Mesoblast Limited
Annual Revenue Comparison: Arrowhead Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.